● Recruiting

Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients

Condition: Spinocerebellar Ataxia · Sponsor: ALPS Biotech CO. LTD

PhaseNA

Planned participants60

Who can joinAll sexes, 30 Years to 70 Years

Healthy volunteersNo

About this study

This study aims to assess the effect of Antrodia cinnamomea on clinical symptoms in spinocerebellar ataxia patients. To investigate the advancements in neurodegenerative diseases.

This description comes directly from the study's public registry record.

Talk to the study team

Yu Hsuan Chang · +886955551989 · hsuan1989@alps.com.tw

Irene Tsai · +886925772995 · ibox526@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Taiwan University Cancer Center

Taipei, Taiwan

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06633003